$NHS

NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION - Neuberger Berman High (AMEX:NHS)

NEW YORK, Sept. 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. ( NYSE:NHS ) ( the "Fund" ) has announced a distribution declaration of $0.0905 per share of common stock.

Original reporting
Benzinga · PRNewswire
Published Sep 30, 2025, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NHS
Neutral
medium confidence
Mentioned
$NHS
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$NHSNeutralLow
01

Why it matters

The declared distribution reinforces the fund's income-generating capacity, which may support its share price but does not indicate a change in fund fundamentals.

02

Market read

The news is relevant primarily to income-focused investors and those with exposure to high-yield bond funds.

03

What to watch

Potential changes in interest rates or credit spreads could influence the fund's performance more significantly than the distribution itself.

Timing: short-term

Background

The Neuberger Berman High Yield Strategies Fund (NHS) is a closed-end fund investing primarily in high-yield bonds, offering income to investors.

Company-level read

Ticker impact

$NHSNeutralMedium confidence
Context

The news pertains directly to the Neuberger Berman High Yield Strategies Fund (NHS), which is a high-yield bond fund.

Expected impact

Potential minor positive stabilization in share price due to income distribution announcement.

Evidence & confidence

Distribution announcements often reinforce investor confidence but do not necessarily lead to significant price movements unless accompanied by other positive developments.

Market effects

The announcement may positively influence investor sentiment toward high-yield bond funds and related fixed income sectors.

Limited regional impact; primarily relevant to US-based investors and markets.

Minimal global market impact; specific to US high-yield bond funds.

Counterpoint

The distribution announcement may be a routine event with limited impact; focus on broader market conditions for trading decisions.

Key entities

  • Neuberger Berman High Yield Strategies Fund Inc.

    A high-yield bond fund providing income to investors.

Related articles

$NHSMed

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) declared a monthly distribution of $0.0905 per common share under its level distribution policy. The payment date is May 29, 2026, with record and ex-dates of June 15, 2026. The fund said future distributions may include net investment income, realized capital gains, and return of capital, depending on market and fee/leverage costs.

$GISMed

General Mills Announces Dana McNabb As CEO

General Mills' board elected Dana McNabb, current COO, as CEO effective January 2027, succeeding Jeff Harmening, who will become executive chair. McNabb, with 27 years at the company, has led key operating segments and functions. She aims to drive profitable growth through digital demand and supply chain modernization, building on Harmening's foundation.

$GISMed

General Mills Names First Woman CEO

General Mills has named Dana McNabb as its next CEO, the first woman to lead the company. McNabb, currently COO, will take over on January 1. Current CEO Jeff Harmening will become executive chairman. The board unanimously approved the change.

$HPEMedAI 8/10

HPE Networking chief links $1.2B Vultr neocloud win to ‘revenue synergy’ opportunity

Hewlett Packard Enterprise (HPE) secured a $1.2B deal with Vultr for its AMD Helios AI Rack system, highlighting revenue synergy opportunities. The deal involves deploying HPE's AI Rack in Vultr's U.S. data centers to support AI workloads. HPE's executive Rami Rahim stated this opens a new networking market, with Helios representing a billion-dollar opportunity over two years, and networking tray orders already exceeding $200M.

$LLYMedAI 8/10

Retatrutide Yields Significant Weight Loss in T2D

Eli Lilly's phase 3 TRIUMPH-2 study shows retatrutide, a triple hormonal agonist, achieved significant weight loss (up to 20.8%) and glycemic improvements in adults with type 2 diabetes (T2D) and obesity. The study, presented at EASD 2026, involved 1152 participants and showed retatrutide's efficacy estimand exceeded 20% weight reduction, a threshold not previously reached in T2D patients.